Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
Gaurav V. Harlalka(University of Exeter), Andrew H. Crosby(University of Exeter), Lailá Bastaki(Kuwait Institute for Medical Specialization), David A. Priestman(University of Oxford), Roselyn Coblentz(Holmes Community College), Saeed Al-Turki(Wellcome Sanger Institute), Anna Lehman(University of British Columbia), Radoslaw P. Kozak(Culham Science Centre), Ajith Sreekantan-Nair(University of Exeter), Karin Wagner(Holmes Community College), Matthew E. Hurles(Wellcome Sanger Institute), Meriel McEntagart(St George's, University of London), Harold E. Cross(University of Arizona), Louise Royle(Culham Science Centre), Barry A. Chioza(University of Exeter), Kamilla Schlade‐Bartusiak(University of British Columbia), Frances M. Platt(University of Oxford), Reza Maroofian(University of Exeter), Emma L. Baple(University of Exeter), Michael A. Patton(St George's Hospital), Joy Price(St George's, University of London), Michelle M. Mezei(Université Paris-Sud), Christos Proukakis(National Hospital for Neurology and Neurosurgery)
Cited by 143
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k